Prevalence of human papillomavirus infection in women in Turin, Italy.

[1]  F. X. Bosch,et al.  Cervical human papillomavirus infection in women attending gynaecological outpatient clinics in northern Greece , 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[2]  S. Franceschi,et al.  Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study , 2004, British Journal of Cancer.

[3]  I. Catalá,et al.  Cervical Human Papillomavirus Infection in the Female Population in Barcelona, Spain , 2003, Sexually transmitted diseases.

[4]  D. Galloway.  Papillomavirus vaccines in clinical trials. , 2003, The Lancet. Infectious diseases.

[5]  N. Muñoz,et al.  Prevalence of Human Papillomavirus Infection Among Women in Concordia, Argentina:: A Population-Based Study , 2003, Sexually transmitted diseases.

[6]  V. Beral,et al.  Human papillomavirus infection and use of oral contraceptives , 2003, British Journal of Cancer.

[7]  S. Franceschi,et al.  HUMAN PAPILLOMAVIRUS INFECTION AMONG WOMEN IN SOUTH AND NORTH VIETNAM , 2003 .

[8]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[9]  P. Coursaget,et al.  Prevalence of human papillomavirus infection in women in Busan, South Korea , 2003, International journal of cancer.

[10]  S. Franceschi,et al.  Prevalence and determinants of HPV infection among Colombian women with normal cytology , 2002, British Journal of Cancer.

[11]  V. Moreno,et al.  Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study , 2002, The Lancet.

[12]  P. Snijders,et al.  GP5+/6+ PCR followed by Reverse Line Blot Analysis Enables Rapid and High-Throughput Identification of Human Papillomavirus Genotypes , 2002, Journal of Clinical Microbiology.

[13]  A. Moscicki,et al.  Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. , 2001, JAMA.

[14]  N. Muñoz,et al.  Epidemiology of HPV infection among Mexican women with normal cervical cytology , 2001, International journal of cancer.

[15]  J. Peto,et al.  Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case–control study nested within the Manchester cohort , 2000, British Journal of Cancer.

[16]  S. Ciatto,et al.  Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirusesting , 2000, British Journal of Cancer.

[17]  J. Kaczorowski,et al.  Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[18]  J. Cuzick,et al.  A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions , 2000, British Journal of Cancer.

[19]  J. Walboomers,et al.  Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: The age‐related patterns for high‐risk and low‐risk types , 2000, International journal of cancer.

[20]  M. Plummer,et al.  Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. , 2000, Journal of the National Cancer Institute.

[21]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[22]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[23]  M. Sherman,et al.  Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  K. Engels,et al.  The polymerase chain reaction in pathology. , 1997, Journal of clinical pathology.

[25]  A. Ponti,et al.  Interaction of spontaneous and organised screening for cervical cancer in Turin, Italy. , 1997, European journal of cancer.

[26]  C. Meijer,et al.  A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings , 1997, Journal of clinical microbiology.

[27]  S. Rosso,et al.  Social class and cancer survival in Turin, Italy. , 1997, Journal of epidemiology and community health.

[28]  N. Muñoz,et al.  Risk Factors for HPV DNA Detection in Middle‐Aged Women , 1996, Sexually transmitted diseases.

[29]  J. Feldman,et al.  Declining Prevalence of Cervicovaginal Human Papillomavirus Infection With Age Is Independent of Other Risk Factors , 1996, Sexually transmitted diseases.

[30]  C. Meijer,et al.  Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes , 1995, Journal of clinical microbiology.

[31]  A. Ponti,et al.  Who does Pap-test? The effect of one call program on coverage and determinants of compliance. , 1994, Epidemiologia e prevenzione.

[32]  L. Brinton,et al.  Determinants of Genital Human Papillomavirus Infection in Low‐Income Women in Washington, D.C , 1993, Sexually transmitted diseases.

[33]  David R. Scott,et al.  Determinants of Genital Human Papillomavirus Infection in Low‐Risk Women in Portland, Oregon , 1993, Sexually transmitted diseases.

[34]  J. Underwood.  Diagnostic Molecular Pathology. A Practical Approach , 1993 .

[35]  J Cuzick,et al.  A systematic review of the role of human papillomavirus testing within a cervical screening programme. , 1999, Health technology assessment.

[36]  J. Higginson,et al.  International Agency for Research on Cancer. , 1968, WHO chronicle.